In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Oncolytics Biotech, Inc (NASDAQ: ONCY) closed at $0.97 down -7.33% from its previous closing price of $1.05. In other words, the price has decreased by -$7.33 from its previous closing price. On the day, 1.09 million shares were traded. ONCY stock price reached its highest trading level at $1.06 during the session, while it also had its lowest trading level at $0.9713.
Ratios:
For a deeper understanding of Oncolytics Biotech, Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 7.50 whereas as Long-Term Debt/Eq ratio is at 5.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on August 13, 2025, initiated with a Buy rating and assigned the stock a target price of $7.
On October 06, 2022, Maxim Group started tracking the stock assigning a Buy rating and target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on February 17, 2021, with a $15 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 104701000 and an Enterprise Value of 91763432.
Stock Price History:
The Beta on a monthly basis for ONCY is 0.99, which has changed by 0.32911396 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.51, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -1.86%, while the 200-Day Moving Average is calculated to be 6.04%.
Shares Statistics:
For the past three months, ONCY has traded an average of 747.71K shares per day and 723390 over the past ten days. A total of 103.64M shares are outstanding, with a floating share count of 98.57M. Insiders hold about 1.79% of the company’s shares, while institutions hold 2.81% stake in the company. Shares short for ONCY as of 1767139200 were 3702064 with a Short Ratio of 4.95, compared to 1764288000 on 3185385. Therefore, it implies a Short% of Shares Outstanding of 3702064 and a Short% of Float of 3.55.
Earnings Estimates
The market rating for Oncolytics Biotech, Inc (ONCY) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.29 and -$0.41 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.34, with 5.0 analysts recommending between -$0.2 and -$0.53.
